PP
EW icon

Pingora Partners’s Edwards Lifesciences EW Stock Holding History

Pingora Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Hold
500
– – 0.02% 140
2025
Q4 		$42.6K Hold
500
– – 0.03% 136
2025
Q3 		$38.9K Hold
500
– – 0.03% 137
2025
Q2 		$39.1K Hold
500
– – 0.03% 134
2025
Q1 		$36.2K Hold
500
– – 0.03% 137
2024
Q4 		$37K Hold
500
– – 0.02% 145
2024
Q3 		$33K Hold
500
– – 0.02% 159
2024
Q2 		$46.2K Hold
500
– – 0.03% 128
2024
Q1 		$47.8K Hold
500
– – 0.03% 140
2023
Q4 		$38.1K Buy
+500
New +$34.8K 0.03% 118

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pingora Partners's EW Position: Q1 2026 in Review

Pingora Partners held its Edwards Lifesciences (EW) position steady in Q1 2026 at 500 shares worth $40K. The position accounts for 0.02% of the portfolio, ranked #140.

Pingora Partners first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $47.8K in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Pingora Partners held 500 shares of Edwards Lifesciences worth $40K as of Q1 2026.
  • Pingora Partners left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up 0.02% of Pingora Partners's portfolio in Q1 2026, its #140 holding.
  • Pingora Partners first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
  • Pingora Partners's Edwards Lifesciences position peaked at $47.8K in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Pingora Partners's 13F filing for Q1 2026, filed 15 May 2026.